Pregnancy complicated by opiate addiction and fetal growth restriction

Journal of Addiction Medicine

Volumn 2, Issue 1, 2008, Pages 17-21

  Helmbrecht, Gary D ^a   Lewis, Kerry M ^a,b   Ebert, Allen ^a,c  

^a Prenatal Diagnosis Center   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c GENESYS REGIONAL MEDICAL CENTER   (United States)

Author keywords

Addiction; Fetus; Intrauterine growth restriction; Opiate dependence; Pregnancy complications; Treatment

Indexed keywords

EID: 70349210559     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e31815ec250     Document Type: Conference Paper

References (6)

1. Wong WM, Lao TT. Abnormal umbilical artery flow velocity wave- form-a sign of fetal narcotic withdrawal? AustNZJ Obstet Gynaecol. 1997;37:358-359.
2. Hill RM, Tennyson LM. Maternal drug therapy: effect on fetal and neonatal growth and neurobehavior. Neurotoxicology. 1986;7:121-139.
3. Zharikova OL, Deshmukh SV, Kumar M, et al. The effect of opiates on the activity of human placental aromatase/CYP19. Biochem Pharmacol. 2007;73:279-286.
4. Burns L, Mattick RP, Lim K, et al. Methadone in pregnancy: Treatment retention and neonatal outcomes. Addiction. 2007;102:264-1170
5. Chang G, Carroll KM, Behr HM, et al. Improving treatment outcome in pregnant opiatedependent women. J Subst Abuse Treat. 1992;9:327-330.
6. Jones HE, Johnson RE, Jasinski DR, et al. Randomized controlled study transitioning opioiddependent pregnant women from short-acting mor-phine to buprenorphine or methadone. Drug Alcohol Depend. 2005;78: 33-38.